RecruitingPhase 4NCT07190495

Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy

Preoperative Ginger for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial


Sponsor

University Tunis El Manar

Enrollment

102 participants

Start Date

Jul 5, 2025

Study Type

INTERVENTIONAL

Summary

This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥ 18 years.
  • Scheduled for elective laparoscopic cholecystectomy under general anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Able to understand the study procedures and provide written informed consent.

Exclusion Criteria6

  • Known allergy or hypersensitivity to ginger
  • Documented history of bleeding disorders or current treatment with anticoagulant agents
  • History of severe postoperative nausea and vomiting or an Apfel score of 4
  • Administration of antiemetic drugs or corticosteroids during the preoperative period
  • Pregnancy or breastfeeding
  • Active gastrointestinal or liver disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGinger

Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy

DRUGPlacebo

Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy


Locations(1)

Mohamed Taher Maamouri University Hospital

Nabeul, Nabeul Governorate, Tunisia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07190495